EPSO publishes a first reaction to the Court of Justice of the EU ruling regarding mutagenesis and the GMO Directive in which European Plant Scientists express their disappointment on the ruling which classifies plants obtained by recent techniques such as CRISPR-Cas9-mediated genome editing as GMO that are subject to extensive pre-market risk evaluations. It is contrary to scientific evidence and as it stands now, it very likely will prevent the use in Europe of such technologies to address food and nutritional security and a more positive impact of agriculture on the environment. EPSO offers to collaborate with policy makers to develop an appropriate regulation addressing the issue of how a product of NBTs differs from those achieved with other breeding approaches to balance potential benefits and risks. See brief statements from EPSO members and partners on the ECJ ruling regarding mutagenesis and GMO Directive.
- Plant Biology Europe 2021 conference online 28.6. – 1.7.2021 – PBE 2021 – early registration deadline extended until 30 April 19/04/2021
- 2nd EC online webinar on Horizon Europe on 21.04.2021: “A successful proposal for Horizon Europe: Scientific-technical excellence is key, but don’t forget the other aspects”. 15/04/2021
- Register for the online workshop “Health and economic benefits of microbiomes” held by the European Parliament’s panel for the Future of Science and Technology on 11.05.2021 15/04/2021